SE0300830D0 - New formulations and use thereof - Google Patents

New formulations and use thereof

Info

Publication number
SE0300830D0
SE0300830D0 SE0300830A SE0300830A SE0300830D0 SE 0300830 D0 SE0300830 D0 SE 0300830D0 SE 0300830 A SE0300830 A SE 0300830A SE 0300830 A SE0300830 A SE 0300830A SE 0300830 D0 SE0300830 D0 SE 0300830D0
Authority
SE
Sweden
Prior art keywords
new formulations
formulation
tolterodine
manufacturing
cocoa powder
Prior art date
Application number
SE0300830A
Other languages
Swedish (sv)
Inventor
Fredrik Nicklasson
Kristina Thyresson
Nils-Olof Lindberg
Alice C Martino
Kristina Lindell
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0300830A priority Critical patent/SE0300830D0/en
Publication of SE0300830D0 publication Critical patent/SE0300830D0/en
Priority to CA002519119A priority patent/CA2519119A1/en
Priority to JP2006506376A priority patent/JP2006521347A/en
Priority to AU2004224556A priority patent/AU2004224556A1/en
Priority to PCT/IB2004/000859 priority patent/WO2004084864A1/en
Priority to BRPI0408743-7A priority patent/BRPI0408743A/en
Priority to CNA2004800080871A priority patent/CN1764441A/en
Priority to MXPA05010314A priority patent/MXPA05010314A/en
Priority to EP04720944A priority patent/EP1605920A1/en
Priority to CL200400625A priority patent/CL2004000625A1/en
Priority to ARP040100982A priority patent/AR043773A1/en
Priority to US10/816,673 priority patent/US20040191345A1/en
Priority to ZA200506710A priority patent/ZA200506710B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A tolterodine-containing pharmaceutical formulation that comprises cocoa powder, process for manufacturing the formulation and use of the formulation for treating overactive bladder.
SE0300830A 2003-03-26 2003-03-26 New formulations and use thereof SE0300830D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0300830A SE0300830D0 (en) 2003-03-26 2003-03-26 New formulations and use thereof
EP04720944A EP1605920A1 (en) 2003-03-26 2004-03-16 Formulations comprising tolterodine and cocoa powder and use thereof
PCT/IB2004/000859 WO2004084864A1 (en) 2003-03-26 2004-03-16 Formulations comprising tolterodine and cocoa powder and use thereof
JP2006506376A JP2006521347A (en) 2003-03-26 2004-03-16 Formulation containing tolterodine and cocoa powder and use thereof
AU2004224556A AU2004224556A1 (en) 2003-03-26 2004-03-16 Formulations comprising tolterodine and cocoa powder and use thereof
CA002519119A CA2519119A1 (en) 2003-03-26 2004-03-16 Formulations comprising tolterodine and cocoa powder and use thereof
BRPI0408743-7A BRPI0408743A (en) 2003-03-26 2004-03-16 formulations comprising tolterodine and cocoa powder and their use
CNA2004800080871A CN1764441A (en) 2003-03-26 2004-03-16 Formulations comprising tolterodine and cocoa powder and use thereof
MXPA05010314A MXPA05010314A (en) 2003-03-26 2004-03-16 Formulations comprising tolterodine and cocoa powder and use thereof.
CL200400625A CL2004000625A1 (en) 2003-03-26 2004-03-24 PHARMACEUTICAL COMPOSITION THAT INCLUDES TOLTERODINE AND COCOA POWDER; ITS USE IN THE MANUFACTURE OF USEFUL DRUG FOR THE TREATMENT OF HYPERACTIVE BLADDER.
ARP040100982A AR043773A1 (en) 2003-03-26 2004-03-24 FORMULATIONS AND ITS USE
US10/816,673 US20040191345A1 (en) 2003-03-26 2004-04-02 New formulations and use thereof
ZA200506710A ZA200506710B (en) 2003-03-26 2005-08-22 Formulations comprising tolterodine and cocoa powder and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300830A SE0300830D0 (en) 2003-03-26 2003-03-26 New formulations and use thereof

Publications (1)

Publication Number Publication Date
SE0300830D0 true SE0300830D0 (en) 2003-03-26

Family

ID=20290785

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300830A SE0300830D0 (en) 2003-03-26 2003-03-26 New formulations and use thereof

Country Status (12)

Country Link
EP (1) EP1605920A1 (en)
JP (1) JP2006521347A (en)
CN (1) CN1764441A (en)
AR (1) AR043773A1 (en)
AU (1) AU2004224556A1 (en)
BR (1) BRPI0408743A (en)
CA (1) CA2519119A1 (en)
CL (1) CL2004000625A1 (en)
MX (1) MXPA05010314A (en)
SE (1) SE0300830D0 (en)
WO (1) WO2004084864A1 (en)
ZA (1) ZA200506710B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1907136B (en) * 2006-07-28 2010-08-25 张新生 Vegetation health care milk-like liquid and preparation method thereof
CN102919739B (en) * 2007-06-13 2014-07-02 大塚制药株式会社 Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
JP5702926B2 (en) 2009-10-16 2015-04-15 東レ・ダウコーニング株式会社 Treatment composition for wiping paper

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB918955A (en) * 1960-05-19 1963-02-20 Thomae Gmbh Dr K Pharmaceutical laxative compositions comprising 4,4-dihydroxy-2-amino triphenylmethane
SE9803986D0 (en) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
JP2001114668A (en) * 1999-10-13 2001-04-24 Meiji Seika Kaisha Ltd Chocolate preparation
SK6412002A3 (en) * 1999-11-11 2002-09-10 Pharmacia Ab Pharmaceutical formulation containing tolterodine and its use

Also Published As

Publication number Publication date
CN1764441A (en) 2006-04-26
ZA200506710B (en) 2006-11-29
WO2004084864A1 (en) 2004-10-07
JP2006521347A (en) 2006-09-21
AR043773A1 (en) 2005-08-10
CA2519119A1 (en) 2004-10-07
EP1605920A1 (en) 2005-12-21
BRPI0408743A (en) 2006-03-28
MXPA05010314A (en) 2006-05-19
AU2004224556A1 (en) 2004-10-07
CL2004000625A1 (en) 2005-01-07

Similar Documents

Publication Publication Date Title
WO2003075857A3 (en) Amino-methyl substituted tetracycline compounds
DK1525177T3 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and use thereof
SI1478339T1 (en) Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
EP1399414A4 (en) Substituted tetracycline compounds for the treatment of malaria
IS7691A (en) Drug formulations for the treatment of tumors
SE0100901D0 (en) New composition
SE0302811D0 (en) Novel compounds
IS8398A (en) Drug formulations for the treatment of tumors
PT1313489E (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BEHCET MUCOSITE, STOMATITIS AND SINDROMA
SE0202539D0 (en) Compounds
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
SE0300831D0 (en) New formulations and use therof
SE0103211D0 (en) New formulations and use thereof
NO20062605L (en) Pharmaceutical formulation containing flavoring substances with improved pharmaceutical properties
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
ATE262893T1 (en) DOSAGE FORMS FOR THE TREATMENT OF ORAL MYCOSES
HRP20031057B1 (en) Tablet comprising cetirizine and pseudoephedrine
WO2005030142A3 (en) Rifalazil formulations
DE60311665D1 (en) PHARMACEUTICAL COMPOSITIONS
SE0300830D0 (en) New formulations and use thereof
SE0202365D0 (en) New formulation and use thereof
SE0001916D0 (en) Novel formulation
WO2006094736A3 (en) Alfuzosin controlled-release formulations